Identification of the structural, architectural, cellular and molecular basis for the skeletal phenotypes that result from genetic/pharmacologic interventions and disease states is essential for translating scientific discoveries into therapeutic innovations. The goal of the Skeletal Phenotyping Core is to provide costefficient, state ofthe art, quality-controlled skeletal phenotyping services to fulfill the unmet needs of junior investigators who are transitioning to an independent career in skeletal biology, of established investigators who are new to skeletal biology and of established skeletal biologists. A key part ofthe mission ofthe Skeletal Phenotyping Core will be education, mentoring and incorporation of novel and innovative services to meet the needs ofthe constituent investigators. Consultation regarding experimental design, specimen handling and data analysis will be provided by Core directors, to insure that the maximal amount of data can be obtained from each specimen/subject. The Core will host didactic teaching sessions, hands-on workshops and seminars designed to educate investigators and to foster collaboration among investigators. A special focus ofthe Core will be mentorship of junior investigators and of those investigators new to skeletal biology. This infrastructure and these activities will 1) enhance the productivity and expand the scope of research being conducted by the Core investigators, 2) promote innovation and incorporation of novel technologies into core services 3) foster synergy across a large and diverse community interested in skeletal research, ultimately leading to levels of success greater than the sum of the individual investigators' projected achievements. This will be achieved by the following specific Aims:
Aim 1 : Provide efficient, high-quality, state-of-the-art skeletal phenotyping services that are not readily supported by individual research grants;
Aim 2 : Provide shared resources, training, and educational services to support new investigators in skeletal biology and to facilitate collaboration among core investigators.

Public Health Relevance

The Skeletal Phenotyping Core will provide state ofthe art|services, training in relevant methodologies and assistance with study design and interpretation of results. The Core will also enhance research by providing access to technologies or expertise that would otherwise not otherwise be available to individual investigators. Through its mentoring of Junior investigators, seminars and hands-on workshops, the Core will enhance the success of established investigators and expand the community of skeletal biologists.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Center Core Grants (P30)
Project #
5P30AR066261-05
Application #
9502918
Study Section
Special Emphasis Panel (ZAR1)
Project Start
Project End
Budget Start
2018-06-01
Budget End
2019-05-31
Support Year
5
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
Noguchi, Takashi; Hussein, Amira I; Horowitz, Nina et al. (2018) Hypophosphatemia Regulates Molecular Mechanisms of Circadian Rhythm. Sci Rep 8:13756
Christov, Marta; Clark, Abbe R; Corbin, Braden et al. (2018) Inducible podocyte-specific deletion of CTCF drives progressive kidney disease and bone abnormalities. JCI Insight 3:
Dedic, Christopher; Hung, Tin Shing; Shipley, Alan M et al. (2018) Calcium fluxes at the bone/plasma interface: Acute effects of parathyroid hormone (PTH) and targeted deletion of PTH/PTH-related peptide (PTHrP) receptor in the osteocytes. Bone 116:135-143
Karaca, Anara; Malladi, Vijayram Reddy; Zhu, Yan et al. (2018) Constitutive stimulatory G protein activity in limb mesenchyme impairs bone growth. Bone 110:230-237
Kiapour, Ata M; Cao, Jiaxue; Young, Mariel et al. (2018) The role of Gdf5 regulatory regions in development of hip morphology. PLoS One 13:e0202785
Farrell, Mariah L; Reagan, Michaela R (2018) Soluble and Cell-Cell-Mediated Drivers of Proteasome Inhibitor Resistance in Multiple Myeloma. Front Endocrinol (Lausanne) 9:218
Cox, Kimberly H; Oliveira, Luciana M B; Plummer, Lacey et al. (2018) Modeling mutant/wild-type interactions to ascertain pathogenicity of PROKR2 missense variants in patients with isolated GnRH deficiency. Hum Mol Genet 27:338-350
Vandoorne, Katrien; Rohde, David; Kim, Hye-Yeong et al. (2018) Imaging the Vascular Bone Marrow Niche During Inflammatory Stress. Circ Res 123:415-427
Herisson, Fanny; Frodermann, Vanessa; Courties, Gabriel et al. (2018) Direct vascular channels connect skull bone marrow and the brain surface enabling myeloid cell migration. Nat Neurosci 21:1209-1217
Wein, Marc N; Foretz, Marc; Fisher, David E et al. (2018) Salt-Inducible Kinases: Physiology, Regulation by cAMP, and Therapeutic Potential. Trends Endocrinol Metab 29:723-735

Showing the most recent 10 out of 53 publications